Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxxon Pharmaccines
Oxford, Oxfordshire, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Oxxon Therapeutics (formerly Oxxon Pharmaccines) was a UK-based biotechnology company specializing in the development of therapeutic vaccines for chronic infectious diseases and cancer. The company's core technology was a heterologous prime-boost immunization strategy designed to stimulate powerful T-cell responses by using different delivery vehicles for the same antigen. Its lead programs included Hi-Vax for the treatment of chronic Hepatitis B and Mel-Vax for metastatic melanoma, both of which reached Phase 2 clinical trials. Oxxon was founded based on research from the University of Oxford and was acquired by Oxford BioMedica in 2007 to bolster their immunotherapy pipeline.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- VaccineDNA vaccineViral vector
- Industry
- Biotech
02
Partnerships
University of Oxford
Beyond the preview
Go deeper on Oxxon Pharmaccines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oxxon Pharmaccines.